Clinical Trials Browser

Phase 1 × Hyaluronoglucosaminidase × 30 days × Clear all

NCT07082270 2026-02-19

Selvigaltin With Standard of Care Treatment for the Treatment of Relapsed/Refractory Multiple Myeloma

Phase 1 Not yet recruiting

Multiple Myeloma